Quest, Paige to collaborate on AI software for pathology

By staff writers

May 25, 2021 -- Quest Diagnostics and Paige plan to collaborate on developing new software that will incorporate artificial intelligence (AI) and digital pathology data to improve cancer diagnosis and care.

Under the agreement, the firms will use Paige's machine-learning expertise for pathology diagnostic data and digitized slides from Quest's AmeriPath and Dermpath businesses to identify markers for cancer and other diseases, Quest said.

The two firms plan to market the software to pathologists and oncologists as well as biopharmaceutical and research organizations. The partnership will start by focusing on solid tumor cancers such as prostate, breast, colorectal, and lung, according to Quest.

Inform works with Paige on digital pathology workflow
Anatomic pathology provider Inform Diagnostics announced it will work with artificial intelligence software developer Paige to implement digital pathology...
Paige and Leica form partnership
Digital pathology company Paige and image analysis technology developer Leica Biosystems announced they have formed a partnership to expand access to...
Grail teams with Quest on blood test for early cancer detection
Cancer diagnostics startup Grail has signed Quest Diagnostics to provide phlebotomy services for its upcoming Galleri multicancer early detection blood...
Quest revenues more than double in Q4
Quest Diagnostics delivered record revenues for its fourth quarter and full year due to high demand for COVID-19 testing.
Quest wins CDC contract to sequence COVID-19 gene variants
Quest Diagnostics has received a contract from the U.S. Centers for Disease Control and Prevention (CDC) to provide genomic sequencing for a project aimed...

Copyright © 2021

Last Updated ls 5/25/2021 2:23:32 PM